KI NMA collaborative grants 2022
The KI Network Medicine Global Alliance (KI NMA) steering group is pleased to announce the availability of limited competitive funds for grant applications by faculty, staff and/or students to conduct collaborative interactions within the Network Medicine Institute and Global Alliance.
Collaborative awards within two categories, research and travel, are offered this year. The intention is to use the grants to initiate and sustain collaborations within the field of network medicine.
Funding can be used for starting a collaboration within network medicine, analysis for ongoing collaborative projects, or travel to another lab. The KI NMA collaborative grant may include support for transportation and accommodation at the host site (which should be an institutional member of the Network Medicine Institute and Global Alliance) for the proposed period of interaction. The funds may also be used for e.g. material used for preliminary data collection in either a new or existing collaborative project.
It is also possible to apply for funds to facilitate writing of a larger grant proposal in the field of network medicine together with one or several partners within the Network Medicine Institute and Global Alliance ,and/or with one or several partners at KI. These should be of collaborative nature, with different disciplines and departments, or with partners from other Swedish institutions being included. Such applications should target major granting agencies (e.g. EC, NIH, SSF, STINT, EIT Health). Applications including a partner from the Network Medicine Institute and Global Alliance will be prioritized based on the evaluation criteria described below.
The awards available are:
- up to 240 000 SEK for larger research projects
- up to 20 000 SEK for travel projects.
A condition for receiving the KI NMA collaborative grant is collaboration within, but not limited to, the NMA. The list of international partners can be found at: https://www.network-medicine.org/members.
Assessment of applications
The applications will be assessed by an evaluation committee composed of members from the KI NMA steering group and external experts. The Internationalisation Advisory Council will thereafter decide which applications will be funded in September 2022.
All applications are assessed on the basis of the following three criteria
- scientific quality and potential of the proposed project
- project feasibility
- prospect for long-term collaborative research, education or innovation within the Network Medicine Institute and Global Alliance
Weighting of these criteria is: 1 + 1 + 1
Scientific quality and potential of the proposed project
- Is the project original, innovative and challenging of current opinions or praxis?
- Does it include an innovative hypothesis, or does it seek to resolve important obstacles for continued progress within the research area?
- Does the project involve new ideas, therapies or interpretations?
- If the project aims are achieved, would that significantly enrich knowledge in the particular research field and knowledge of health, disease and healthcare?
- Does the project have clinical impact – both clinical relevance and potential to implement results clinically in the future?
- Are the total financial resources realistic in relation to the scope of the proposed collaboration/grant application?
- Is there sufficient methodological competence to implement the project in the manner described?
- Are there other experiences that in combination with the applicants’ various competencies strengthen the project feasibility?
- Are materials, patients and methods well-chosen and adjusted for the hypothesis?
- What are the strengths and weakness of the chosen approach?
- Is the project ethically sound?
Prospect for long-term collaborative research, education or innovation within the Network Medicine Institute and Global Alliance
- Is the research plan consistent with the expertise, research focus and equipment of collaborating parties?
- Is there a demonstrated division of tasks and activities between the collaborating labs?
- Do factors exist that could emphasize the coherence of the proposed project, such as prior collaborative efforts as evidenced by common publications and/or grants?
- Does the application make clear that the achievement of the project goals is dependent on the participation and interaction of both supervisors and on their complementary skills and knowledge?
5 points = outstanding
4 points = excellent
3 points = very good
2 points = good
1 points = insufficient
Written feedback to applicants
There will be no written feedback to the applicants. All applicants will receive an e-mail with a decision.
Application process and deadline
The deadline for grant proposals is 31st August 2022. Proposals must be submitted via email to email@example.com. Proposals submitted after the deadline will not be considered. The application should be sent in as a single PDF file, be no more than four pages long with normal margins and minimum 11 point font, and should reflect the criteria used for assessment (and include a short budget plan. Please mark the application with Dnr 2-1214/2022. CV for main applicant/applicants is not included in the four-page limit and can be sent as a separate file.
Decisions will be communicated by 31st October 2022 and grants can be used for one year after issue.
For any questions regarding the application please contact Mia Bjerke. For more information about KI Network Medicine Alliance and to read more about our partners and the Network Medicine Institute and Global Alliance.